• O-propargyl-puromycin: Illuminating Protein Synthesis in Imm

  2026-05-16

  Explore how O-propargyl-puromycin (OPP) empowers translational researchers to dissect the mechanistic links between mitochondrial integrity and protein synthesis during adaptive immune responses. Drawing on recent advances in B cell biology and the pivotal role of Pcbp1, this article offers actionable guidance on leveraging OPP for cutting-edge proteomics and cell biology applications.

• Acacetin-Mediated Mitophagy Suppression of Pyroptosis in IVD

  2026-05-15

  This study uncovers a novel mechanism by which Duhuo Jisheng Decoction and its key component acacetin alleviate intervertebral disc degeneration (IVDD) through regulation of the MAPK1/HMOX1 axis, promoting mitophagy and inhibiting pyroptosis in nucleus pulposus cells. The findings offer a mechanistically grounded basis for therapeutic strategies targeting mitophagy–pyroptosis crosstalk in degenerative disc disease.

• Lactate-GPR81/FARP1 Axis Drives Insulin-Independent Glucose

  2026-05-15

  This study uncovers a lactate-driven GPCR signaling pathway—GPR81/FARP1—that promotes insulin-independent glucose uptake in skeletal muscle via RAC1-mediated GLUT4 translocation. These findings offer mechanistic insight into exercise-induced glycemic control and identify GPR81 as a potential therapeutic target for metabolic disorders.

• p-Cresyl Sulfate in Endothelial Dysfunction and Calcificatio

  2026-05-14

  p-Cresyl sulfate (p-tolyl hydrogen sulfate) is transforming the modeling of cardiovascular risk and vascular complications in chronic kidney disease research. This article details advanced workflows, protocol enhancements, and troubleshooting strategies for leveraging APExBIO's high-purity p-Cresyl sulfate in reproducible endothelial dysfunction and calcification assays.

• GOT1 Inhibition by Ziprasidone Alters Redox and Glutamine Pa

  2026-05-14

  This study demonstrates that ziprasidone functions as a non-competitive inhibitor of GOT1, inducing glutamine metabolism reprogramming and redox imbalance in pancreatic ductal adenocarcinoma (PDAC) cells. These insights highlight GOT1 as a promising metabolic target, informing new strategies for redox-focused translational research in cancer.

• PR-619: Deubiquitylating Enzymes Inhibitor in Assay Design

  2026-05-13

  PR-619 from APExBIO stands out as a potent, reversible deubiquitylating enzymes inhibitor, uniquely suited for dissecting the ubiquitination pathway in cancer and neurodegeneration research. Explore optimized workflows, troubleshooting strategies, and the latest reference-backed insights to maximize reproducibility and data depth with this versatile tool.

• HATU in Peptide Synthesis Chemistry: Precision & Performance

  2026-05-13

  HATU accelerates high-fidelity amide and ester formation, driving next-generation peptide synthesis workflows with superior efficiency and minimized epimerization. Explore hands-on protocol enhancements, troubleshooting strategies, and translational insights directly informed by breakthrough inhibitor discovery studies.

• GPER1 as a Chemopreventive Target in Prostate Cancer Progres

  2026-05-12

  This study identifies G-protein coupled estrogen receptor 1 (GPER1) as a promising target for chemoprevention in prostate cancer. By integrating analyses from clinical samples and the TRAMP mouse model, the researchers show that GPER1 activation inhibits malignant progression, highlighting new avenues for early intervention and mechanistic investigation.

• Nigericin Sodium Salt: Advancing Ion Transport Research

  2026-05-12

  Explore the mechanistic depth and translational strategy behind Nigericin sodium salt—a precision potassium ionophore—highlighting its value in cell biology, toxicology, and in vitro drug response research. This thought-leadership article integrates recent scientific frameworks with actionable protocol guidance, uniquely positioning Nigericin sodium salt as a transformative tool for translational scientists.

• Selective Autophagy Regulates IRF3 for Balanced Interferon R

  2026-05-11

  This study uncovers how selective autophagy, mediated by the cargo receptor CALCOCO2/NDP52 and regulated by deubiquitinase PSMD14, controls the degradation and stability of the transcription factor IRF3. These findings clarify the mechanisms that maintain balanced type I interferon signaling and immune suppression during viral infection, offering new insights into the regulation of transcription factors in innate immunity.

• V5 Epitope Tag Peptide: Precision Protein Tagging for Wester

  2026-05-11

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) enables high-specificity detection and purification of recombinant proteins across diverse workflows—from Western blotting to single-molecule super-resolution imaging. APExBIO’s high-purity V5 tag streamlines multiplexed experiments and troubleshooting, outperforming legacy tags in solubility and minimal protein interference.

• Sodium Orthovanadate: Mechanistic Leverage for Translational

  2026-05-10

  Explore how Sodium Orthovanadate (Na3VO4) empowers translational researchers to interrogate phosphorylation-driven signaling and metabolism, with actionable protocols, cross-study insights, and strategic guidance for maximizing data fidelity. Drawing on both foundational mechanisms and current translational challenges, this article offers a differentiated, evidence-backed perspective for advanced research planning.

• Navigating Chemoresistance: Tariquidar & the Tumor Microenvi

  2026-05-09

  This article provides a mechanistic and strategic exploration of how Tariquidar (XR9576) empowers translational researchers to dissect and overcome chemoresistance driven by mechanical cues—specifically high-viscosity tumor microenvironments that upregulate P-glycoprotein (P-gp). Integrating cutting-edge mechanobiology, actionable protocol guidance, and competitive insights, it positions Tariquidar as an indispensable tool for advanced transporter-mediated drug disposition and cancer chemoresistance studies.

• Verbascoside: Precision PKC/NF-κB Inhibition for Bone Signal

  2026-05-08

  Explore the unique role of Verbascoside as a PKC/NF-κB inhibitor in dissecting bone metabolism and osteoclastogenesis. This article delivers fresh insight into mechanistic studies and assay optimization, grounded in recent advances and practical guidance.

• PERK-Dependent JAK1–STAT3 Activation Drives Pyroptosis in ID

  2026-05-08

  This study elucidates how unresolved endoplasmic reticulum stress (ERS) in nucleus pulposus cells (NPCs) promotes pyroptosis and inflammation via PERK-driven JAK1–STAT3 signaling. By defining the mechanistic link between the PERK/eIF2α/ATF4 axis and inflammatory cell death, it identifies potential therapeutic targets to mitigate intervertebral disc degeneration (IDD) progression.

506 records 8/34 page Previous Next First page 上5页 678910 下5页 Last page